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Brown adipocytesSkeletal muscle has strong regenerative capabilities. However, failed regeneration can lead to complications
where aberrant tissue forms as is the case with heterotopic ossiﬁcation (HO), inwhich chondrocytes, osteoblasts
and white and brown adipocytes can arise following severe trauma. In humans, the various HO cell types likely
originate frommultipotentmesenchymal stromal cells (MSCs) in skeletalmuscle, which have not been identiﬁed
in humans until now. In the present study, adherent cells from freshly digested skeletal muscle tissue were ex-
panded in deﬁned culture medium and were FACS-enriched for the CD73+CD105+CD90− population, which
displayed robust multilineage potential. Clonal differentiation assays conﬁrmed that all three lineages originated
from a single multipotent progenitor. In addition to differentiating into typical HO lineages, human muscle resi-
dent MSCs (hmrMSCs) also differentiated into brown adipocytes expressing uncoupling protein 1 (UCP1). Char-
acterizing this novel multipotent hmrMSC population with a brown adipocyte differentiation capacity has
enhanced our understanding of the contribution of non-myogenic progenitor cells to regeneration and aberrant
tissue formation in human skeletal muscle.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
Skeletal muscle possesses a remarkable capacity to regenerate fol-
lowing trauma, mainly through myogenic stem cells [1]. However, efﬁ-
cient tissue repair also requires the activation of resident cells within
the stroma, notably mesenchymal stromal cells (MSCs). Inappropriate
activation can lead to aberrant tissue formation such as heterotopic os-
siﬁcation (HO), where extra-skeletal bone forms, most commonly in
muscle, through an endochondral process [2–4]. While HO can arise
from ﬁbrodysplasia ossiﬁcans progressiva (FOP), an uncommon heredi-
tary disease, most cases result from a local trauma (surgery, muscular
trauma, fractures) or neurological injury [5]. Traumatic HO has beennchymal stromal cell; hmrMSC,
erbrooke, QC, Canada, J1H 5N4.
. Grenier).
. This is an open access article underthought to result from the inappropriate differentiation of muscle-
resident progenitor cells, induced by a pathological imbalance of local
or systemic factors [6]. However, the cellular origin of the ectopic
bone in HO remains a matter of debate [7].
While local muscle resident MSCs are a logical candidate as HO pro-
genitors, other cells have been proposed. Some studies have implicated
vascular endothelial cells as a potential source for HO progenitors [8].
Constitutively activated ACVRI in FOP change the morphology of endo-
thelial cells to mesenchymal-like cells and induce the co-expression of
mesenchymal markers in vitro, a process that resembles the endotheli-
al–mesenchymal transition [8]. Moreover, endothelial marker Tie2 has
been histologically observed in heterotopic lesions from patients with
FOP. In addition, lineage tracing studies using Tie2-Cre reportermice in-
dicated that these cells generate approximately half the chondrocytes
and osteoblasts found in skeletal muscle lesions [8,9]. However, Tie2 is
not speciﬁc to endothelial cells and is also expressed in a number of
non-endothelial cell types, including perivascular cells [10,11]. It has
also been shown in vivo that the endothelial fraction of murine Tie2the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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endothelial fraction of Tie2 cells (Tie2+CD31−) does [12]. These recent-
ly published ﬁndings strongly suggest that the Tie2 progenitors ob-
served in HO are not of endothelial origin [7]. Indeed, more than 90%
of Tie2+CD31− cells are also PDGFRα+Sca1+, pointing to a mesenchy-
mal rather than an endothelial origin [12], which supports the ﬁndings
of Leblanc et al., who showed that a Sca1+CD31−muscle resident stro-
mal cell population contributes to HO [2].
In humans, PDGFRα has been reported to be a speciﬁcmarker for in-
terstitial mesenchymal progenitors that are distinct from CD56+ myo-
genic cells and that possess adipogenic and ﬁbrogenic potentials [13].
While human skeletal muscle PDGFRα+ cells display osteogenic poten-
tial in vivo [14], the conﬁrmation of their osteogenic activity came from
subcutaneous-implanted cell-loaded PLGA-hydroxyapatite blocks,
which are not likely representative of the HO environment. In addition,
their osteogenic activity was comparable to CD56 myogenic cells [14],
suggesting that PDGFRαmay not be a marker that is exclusive to osteo-
genic progenitors. Other human studies have shown that a fraction of
skeletal muscle adherent cells can give rise to osteoblasts and that this
potential is greatly increased following trauma [15,16]. A multipotent
myo-endothelial cell population in human skeletal muscle has been
characterized based on the presence of myogenic (CD56) and endothe-
lial (CD34, CD144) cell surface markers and the ability to differentiate
into mesenchymal lineages [17].
Interestingly, the brown adipogenic potential of these putative HO
progenitors has not been investigated, although it has been shown
that brown adipocytes can promote endochondral ossiﬁcation in an
HOmouse model by regulating oxygen availability and inducing a hyp-
oxic microenvironment [18,19]. Until now, an adult human skeletal
muscle-derived progenitor cell population giving rise to brown adipo-
cytes has not been characterized. While uncoupling protein 1 (UCP1)
mRNA expression in adult human whole skeletal muscle has been re-
ported, the identity of the responsible progenitors is not known [20].
Given the varied tissuemake-up of HO, no adult human skeletalmus-
cle resident progenitor cells have been identiﬁed that can differentiate
into mesenchymal as well as brown adipogenic lineages. We enriched
human muscle resident mesenchymal stromal cells (hmrMSCs) and,
for the ﬁrst time, showed that hmrMSCs are clonally capable of efﬁcient
differentiation toward osteogenic, chondrogenic and adipogenic line-
ages. Interestingly, these hmrMSCs were also able to differentiate into
UCP1-expressing brown adipocytes, cells that we also detected in
human HO samples, which lends credence to a possible role for them
in the development of HO. A better understanding of the cellular origin
responsible for HO will provide a potential therapeutic target to treat,
mitigate, or prevent this debilitating condition.
Materials and methods
Human tissue
Healthy human skeletal muscle tissue samples (gracilis and
semitendinosus) were obtained from patients (34 ± 8 years of age;
54%male and 46% female) undergoing anterior cruciate ligament recon-
struction surgery. HO tissue was obtained from a 21-year-old male pa-
tient who had developed a mass in the gluteal muscle following a
mid-shaft femur fracture (Table S1). The sampleswere collected follow-
ing resection surgery. The protocols were approved by the Centre
Hospitalier de l'Université de Sherbrooke Ethics Committee (#11-122
and #13-164), and written consent was obtained from the patients.
Cell isolation and culture
Carefully dissected skeletal muscle samples were minced and then
digested for 30 min at 37 °C with 1 mg/mL of collagenase type I
(Sigma) in DMEM containing 10% FBS. The tissue slurry was diluted
with medium, passed through 70-μm and 40-μm cell strainers (BectonDickenson) and centrifuged at 325 g for 6 min at 4 °C. Primary human
skeletal muscle cells were seeded in tissue culture plates coated with
Mesencult-SF® attachment substrate and were expanded as adherent
cells in Mesencult-XF® medium (StemCell Technologies). After 7 days,
an average of 7 × 105 adherent cells were recovered per gram of tissue.
The cells were trypsinized at 80% conﬂuence and were centrifuged and
resuspended inMesencult-XF®mediumasﬁrst passage cells, with fresh
medium changes every 3–4 days. The cells were sub-cultured at a den-
sity of 4 × 103 cells/cm2.
Fluorescent activated cell sorting
First passage cells were detached with the Accutase™ Cell
Detachment solution (BD Biosciences), centrifuged and resuspended
at ~1 × 106 cells per ml in cold sorting buffer (PBS, 1 mM EDTA,
25 mM HEPES, pH 7.0, 1% FBS). The cells were incubated for 20 min
on ice with the appropriate primary antibodies (Table S2) according
to the manufacturers' instructions. During the cell sorting experiment,
live cells were distinguished from dead cells using LIVE/DEAD® Violet
Viability/Vitality kits (Invitrogen). Fluorescence was compensated
using BD CompBeads Set Anti-Mouse Ig, κ (BD Biosciences). The cells
were sorted a BD FACSAria™ cell sorter (BD Biosciences) equipped
with four lasers and a 100-μm nozzle set at 20 psi. Sorting gates were
deﬁned based on unstained controls. The cells were analyzed using
FlowJo 7.9 software (Treestar Inc.). A population of unsorted cells was
used as a control. Unsorted and sorted fractions were then expanded
as described above.
Differentiation protocols
The osteogenic, chondrogenic and white and brown adipogenic dif-
ferentiation protocols were adapted from published protocols [21-24]
and are presented in Table S3. Brieﬂy, for the osteogenic, adipogenic
(white and brown) and myoﬁbroblastic assays, the cells were seeded
at a density of 8 × 103 cells per well in 24-well collagen-coated
(Millipore) plates (4000 cells/cm2) in Mesencult-XF® medium and in-
cubated at 37 °C in a CO2 incubator until they reached conﬂuence.
For osteogenic differentiation, the cells were cultured in osteogenic
medium (Table S3) for 21 days. Unstimulated cells were cultured in os-
teogenic basal medium (DMEM, 5% horse serum [HS]). To assessminer-
alization, calciumdeposits in cultureswere stainedwith 40mMAlizarin
Red-S, pH 4.1).
For white adipogenic differentiation, the cells were cultured in
adipogenic inductionmedium for 3 days and then in adipogenic growth
medium (Table S3) for a further 18 days for oil Red O staining, or
11 days for gene expression analyses. Unstimulated cells were cultured
in adipogenic induction/growth basalmedium(DMEM, 3%/10% FBS). An
oil red O solution (0.5% oil red O in isopropyl alcohol; Sigma) was used
to detect triglycerides in the lipid droplets of mature adipocytes.
Alizarin red- and oil red O-stained area was quantiﬁed using ImageJ
software (version 1.46, National Institute of Health) [25].
For brown adipogenic differentiation, the cells were incubated in
adipogenic induction medium for 3 days and then in brown adipogenic
growth medium (Table S3) for a further 11 days. Unstimulated cells
were cultured in the same adipogenic basal media as the stimulated
cells (DMEM, 3%/10% FBS).
To stimulate chondrogenesis, ~2.5 × 105 cells were pelleted by cen-
trifugation (350 g, 6 min, 4 °C) and were resuspended in chondrogenic
culture medium (Table S3). Unstimulated cells were cultured in
chondrogenic basal medium (serum-free DMEM). The cells were har-
vested by centrifugation on day 21. The pellets were ﬁxed in 4% phos-
phate buffered formalin and were embedded in parafﬁn. Sections
(5 μm) cut using an HM325 microtome (Micron) were immersed in
anAlcian blue solution (1% Alcian blue in 3% acetic acid; Acros Organics)
to stain highly sulfated proteoglycans that characterize the cartilaginous
matrix.
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ed in myoﬁbroblastic differentiation medium (Table S3) for 5 days.
The TGFβwas omitted for the unstimulated controls.
The differentiation media used for all the procedures were changed
twice every 3 or 4 days.
Clonal growth and differentiation
CD73+CD105+CD90− hmrMSC clones were established by limiting
dilution. Brieﬂy, second passage cells were resuspended at a concentra-
tion of less than 1 cell per 200 μl in Mesencult-XF® medium and were
plated in Mesencult-SF® attachment substrate-coated 96-well plates
(200 μl per well). After 72 h, wells with a single cell were identiﬁed.
After 2–3 weeks, single cell-derived clones were passaged, expanded
and differentiated in osteogenic, adipogenic, or chondrogenic medium
(Table S3) for 21 days.
Quantitative PCR
qPCR was performed as previously described [2]. Total RNA was
extracted using TRIzol® (Invitrogen) according to the manufacturer's
instructions. TheRNAwas precipitatedwith isopropanol and1 μg of gly-
cogen, rinsed with ethanol and resuspended in RNAse-free water. The
RNA was reverse-transcribed using RT Superscript II kits (Invitrogen).
The qPCR reactions were prepared with 2× SYBR green master mix
(BioRad). The samples were then placed in a RotorGene 6000 (Corbett
Robotics). The qPCR conditions were as follows: 10min at 95 °C, 40 cy-
cles of 40 s at 95 °C and 40 s at 56 °C. The results were analyzed using
the 2−ΔΔCT relative quantiﬁcation method normalized to the TATA-
box binding protein (TBP). The primer sets for the adipogenic and
chondrogenic genes were selected from other studies [16,21,26]. Com-
mercial primers were used for the osteogenic genes SP7 (Hs_SP7_1_SG,
QuantiTec Primer Assays) and DLX5 (Hs_DLX5_1_SG, QuantiTec Primer
Assays). The primer sets are listed in Table S4.
Western blots
Western blots were performed as previously described [27]. Brieﬂy,
the cells were lysed on ice in RIPA buffer containing protease inhibitors
(Complete™; Roche Molecular Biochemicals). The homogenate was
centrifuged, the supernatant containing the proteins was recovered
and the protein concentrations were determined using the Bradford
method (BioRad). Proteins were separated by polyacrylamide gel
electrophoresis (PAGE) and were transferred to PVDF membranes
(Millipore). The membranes were incubated with anti-UCP1 (1:1000,
ab10983; Abcam) and anti-GAPDH (1:1000, FL-335; Santa-Cruz) anti-
bodies overnight at 4 °C. The membranes were rinsed in PBS-T and
were then incubatedwith the appropriate secondary HRP-coupled anti-
bodies (1:5000; Amersham) at RT for 1 h. After several rinses with PBS-
T, the membranes were incubated in an ECL solution, and the signals
were detected using Biomax ML ﬁlm (Kodak). The images were digi-
tized, and the bands were quantiﬁed using ImageJ software.
Histology and immunohistochemistry
HO tissue was prepared for histology and immunohistochemistry
following resection as previously described [28,29]. Half the tissue was
formalin-ﬁxed and was embedded in 4.5% methyl methacrylate
(MMA). Sections (6 μm) cut using a Leica Polycut SM2500 (Leica
Microsystems) were deplastiﬁed and stained with Goldner trichrome
for comparative histology.
The remaining tissue was decalciﬁed and was immunolabeled with
an anti-UCP1 antibody (1:500, ab10983; Abcam). The immunolabeling
was ampliﬁed using avidin–biotin (Vector Laboratories) and was re-
vealed using DAB peroxidase substrate kits (Vector Laboratories). The
sections were counterstained with Mayer's hematoxylin.Immunoﬂuorescence
Cultured cells were immunolabeled as previously described [30].
Brieﬂy, PFA-ﬁxed cells were blocked/permeabilized (PBS containing
10% goat serum, 1% BSA and 0.2% Triton® X-100) and were then
incubated with anti-UCP1 (1:800, ab10983; Abcam) or anti-α-SMA
(1:100, CLSG36501-05, Cedarlane) primary antibodies for 90 min at
RT. After several rinses in PBS-Tween, the cells were incubated with
Alexa Fluor®594-conjugated secondary antibody (1:1000, Invitrogen).
Cell nuclei were stained with DAPI (Sigma-Aldrich). Samples in which
the primary antibodies were omitted served as controls. Indirect immu-
noﬂuorescence was examined without counterstaining using an
Axioskop 2 phase-contrast/epiﬂuorescence microscope (Carl Zeiss,
Inc.) or a DMIRE2 inverted microscope (Leica Microsystems). Photomi-
crographic imageswere captured using a Retiga SRV cooled color digital
camera (Qimaging) and were processed using Adobe Photoshop CS5.
Results and discussion
Multiple lineages including UCP1-expressing adipocytes in human HO
HO is characterized by the inappropriate activation of MSCs in skel-
etal muscle leading to extra-skeletal bone tissue-containing cells from
multiple lineages [2,29]. Fig. 1A shows an anteroposterior X-ray of HO
tissue in human gluteal muscle following orthopedic trauma. Histologic
examinations of Goldner trichrome-stained resin sections conﬁrmed
the presence of several distinct tissue types (Fig. 1B), including mature
bone (green) (Fig. 1C), cartilage (orange-red) (Fig. 1D) and adipocytes
with large lipid-ﬁlled vacuoles (Fig. 1E). It has been suggested that the
presence of oxidative brown adipocytes in a mouse model of HO sup-
ports bone growth by reducing oxygen availability, which contributes
to angiogenesis and endochondral ossiﬁcation [18,19]. Thewhite adipo-
cytes were observed in large numbers unlike the small clusters of
multilocular adipocytes which are UCP1 positive, a speciﬁc brown
adipogenic marker [31,32]. Brown adipocytes clusters were located ei-
ther near muscle ﬁbers or the ﬁbrocartilage and chondrocyte regions
(Fig. 1F). Similar results were obtained in three other HO samples
(Table S1). These ﬁndings conﬁrmed the presence of brown adipocytes
in HO, corroborating previous mouse studies[18,19] and provide the
ﬁrst evidence of brown fat in a human skeletal muscle regenerative
disorder.
Isolated CD73+CD105+CD90− hmrMSCs are clonally multipotent
To isolate adult human skeletal muscle MSCs, whichmay be respon-
sible for the aberrant tissue types in HO, dissociated cells from six
donors (Table S1) were independently grown in deﬁned culture medi-
um. Adherent cells from each sample were sorted by FACS based on
the differential expression of characteristic mesenchymal (CD73,
CD105), hematopoietic (CD34) and endothelial (CD31) cell surface
markers (Fig. 2A) [33]. Hematopoietic and endothelial cell types were
excluded by CD34− and CD31− gating of viable cells. An initial stromal
subset was obtained based on the CD73+ and CD105+markers. We re-
ﬁned our isolation procedure by sorting the CD73+CD105+ cells based
on the presence or absence of CD90. There is, in fact, no consensus on
the status of CD90 as a true MSC marker. Some studies have reported
that cell populations with high levels of CD90 expression are
multipotent MSCs, whereas others have categorized CD90 as a
ﬁbroblastic marker [33,34]. Care must be taken in interpreting these re-
sults since culture conditions have been shown to modulate the
immunophenotypes of human stem cells in vitro [35]. However, in de-
ﬁned culture media, the human skeletal muscle CD73+CD105+CD90−
(or CD90−) and CD73+CD105+CD90+ (or CD90+) populations made
up 11 ± 8% and 41 ± 2% of total viable cells, respectively (Fig. 2A).
We evaluated the osteogenic, adipogenic and chondrogenic differ-
entiation potentials of the unsorted, CD90− and CD90+ cell populations
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Fig. 1. Heterotopic ossiﬁcation in human skeletal muscle contains differentiated cells from
mesenchymal and brown adipocyte lineages. Representative images from one (HO-1) of
four donors tested. (A) X-ray of heterotopic ossiﬁcation (HO;white arrowhead) in the glu-
teal muscle of a patient one year after the initial trauma. (B) Lowmagniﬁcation of the HO
tissue stained with Goldner trichrome. Mature bone (MB) in green, cartilage (Ch) in red-
orange and adipose (Ad) tissue. (C) Mature bone (MB) with osteon. At higher magniﬁca-
tion, osteoblasts (OB) lining the mature bone can be seen. (D) At higher magniﬁcation,
mineralized andnon-mineralized chondrocytes (MChandNMCH, respectively) can be dis-
tinguished. (E)White adipocyteswith characteristic lipid droplets. (F) Immunostaining for
UCP1-expressing adipocytes suggests the presence of brown adipocytes.
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ferentiated into osteoblasts, as conﬁrmed by the formation of alizarin-
stained mineralized nodules; adipocytes, as conﬁrmed by oil red O-
stained lipid droplets; and chondrocytes as conﬁrmed by tissue
morphology and Alcian blue staining. In contrast, the unsorted cells
displayed mixed differentiation potentials, with alizarin-stained miner-
alization similar to that obtained with the CD90− cells, but limited
adipogenic and chondrogenic differentiation. Quantitative densitome-
try analyses of alizarin red staining revealed 86.4 ± 7.3% coverage for
unsorted cells compared to 95.9 ± 3.7% and 25.1 ± 28.3% for CD90−
and CD90+ cells, respectively, while quantitative analyses of oil red O
staining revealed 12.5 ± 9.7% coverage for unsorted cells compared to
95.4 ± 2.6% and 0.9 ± 1.1% for CD90− and CD90+ cells, respectively.Our results differ from those reported by Nesti et al., who showed
that the CD90+-derived subpopulation is enriched in multipotent cells
[16]. However, our populationwas isolated from untraumatizedmuscle
and was expanded in a deﬁned culture medium. The CD90+ cells
displayed minimal differentiation towards all three lineages but
expressedα-smoothmuscle actinwhen stimulatedwith TGFβ, suggest-
ing that myoﬁbroblastic progenitors were present, as others have
shown [36,37] (data not shown). These results indicated that the
CD90− cell subpopulation contains hmrMSCs that are capable of differ-
entiating into the lineages observed in HO.
To determinewhether these CD90− hmrMSCs arise from a common
progenitor, we isolated clones from the CD90− population to determine
their lineage commitment and differentiation potential. Nine clones de-
rived from a single donor (Table S1) were obtained from 576 plated
wells by limiting dilution (clonal efﬁciency of ~1.6%) andwere assessed
for their differentiation potential toward the osteogenic, adipogenic and
chondrogenic lineages. Four clonal progenies (~44%) differentiated into
all three lineages (Fig. S1); three (~33%) displayed bipotent capabilities
and differentiated into the osteogenic and adipogenic or adipogenic and
chondrogenic lineages; whereas one (~11%) was unipotent and differ-
entiated only into the adipogenic lineage. One of the nine clones failed
to differentiate, probably due to senescence. The clonal assay showed
that the CD90− hmrMSCs contained single progenitor cells with multi-
ple lineage differentiation capabilities. The fact that certain clones were
not tripotent suggested that other, more committed progenitors are
present in this population.
Characterization of CD90− hmrMSC multipotency and differentiation into
UCP1-expressing brown adipocytes
The multipotent differential potential of the CD90− cells was con-
ﬁrmed by qPCR. Bone morphogenetic proteins (BMPs) play a critical
role in the commitment of MSCs and the induction of osteoblastic activ-
ity [38,39]. To assess the osteogenic differentiation potential, we used
BMP9, the most potent osteogenic BMP [40], which efﬁciently induces
the osteogenic program of mouse progenitor muscle resident stromal
cells [2] and for which a role in the development of human HO was
proposed [29]. BMP9 signiﬁcantly increased the expression of the oste-
ogenic markers SP7 andDLX5 in CD90− cells compared to unstimulated
cells (Fig. 3A).
The chondrogenic potential of the CD90− population was also veri-
ﬁed under standard chondrogenic conditions using TGFβ, a known
chondrogenic inductor [41]. Compared to the unstimulated control,
TGFβ signiﬁcantly increased cartilage-speciﬁc collagen II (Col2A1) and
proteoglycan core aggrecan (ACAN) gene expression within 3 and
14 days, respectively (Fig. 3B).
We also assessed the white and brown adipogenic potentials of the
CD90− population. Unlike white adipocytes, brown adipocytes are spe-
cialized in adaptive thermogenesis inwhichUCP1 plays a key role and is
a speciﬁc marker of this cell type [31,32]. Since UCP1-expressing adipo-
cytes are present in human HO (Fig. 1F) and since the CD90− hmrMSC
population has a strong adipogenic potential in vitro (Fig. 2B), we deter-
mined whether this population could give rise to white adipocytes or
UCP1-expressing brown adipocytes. Human adipose-derived stem
cells can differentiate into white or brown adipocytes depending on
the length of rosiglitazone (ROS) treatment in adipogenic differentia-
tion medium [42]. We used this approach with the CD90− cells to
drive white and brown adipocyte formation. Gene expression analyses
revealed that the levels of the general adipogenic factors FABP4, ADIPOQ
and PPARγ were higher in the white (ROS 3d) and brown (ROS 14d)
adipogenic conditions than in the unstimulated control (Fig. 3C). At
day 14, brown adipocyte marker UCP1 mRNA levels were signiﬁcantly
higher in the cell preparations treated to induce white (ROS 3d) and
brown (ROS14d) adipocyte formation (38- and4900-fold, respectively)
than in the unstimulated control (Fig. 3C). The increase in UCP1 expres-
sion was conﬁrmed by immunoﬂuorescence and Western blotting
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168 J. Downey et al. / Bone 71 (2015) 164–170(Figs. 3D, E). However, UCP1 protein levels were similar in the white
and brown differentiation conditions (Fig. 3E), suggesting a mixed
adipogenic population of white and brown adipocytes.
Olmsted-Davis et al. reported that brown adipocyteswere present in
a murinemodel of HO triggered by BMPs, which drive the early steps of
heterotopic endochondral ossiﬁcation by lowering oxygen tension in
adjacent tissue [19]. Moreover, recent results have suggested that
BMPs also induce neurogenic inﬂammation,which enhances adrenergic
stimulation by the sympathetic nervous system (SNS) [43]. The SNS is
known to induceUCP1-expressing brown adipocytes, likely through ad-
renergic stimulation [44]. Further studies are required to gain a betterunderstanding of the effect of SNS stimulation on human muscle resi-
dent progenitor cells in HO.
Conclusions
Weare theﬁrst to show thatUCP1-positive adipocytes are present in
human HO. We are also the ﬁrst to enrich a subpopulation of CD90−
hmrMSCs from adult human skeletal muscle that can give rise to all
the lineages present in HO (osteogenic, chondrogenic and adipogenic
(white and brown)). The characterization of this progenitor cell sub-
population is essential for understandingmuscle regenerative disorders
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Fig. 3. Characterization of themultilineage differentiation potential of CD73+CD105+CD90− hmrMSCs progenitors. (A) qPCR of osteogenic genes after 7 days of BMP9 stimulation. Genes
were normalized to TATA-binding protein (TBP). Data are expressed asmeans± SEM (n=4,N=3). ***P b 0.002; ****P b 0.0001. (B) qPCR of early chondrogenic Col2A1 gene expression
following 3 days of TGFβ stimulation, and late chondrogenic ACAN gene expression following 14 days of TGFβ stimulation. Data are expressed as means ± SEM (n = 4, N = 3).
***P b 0.001; ****P b 0.0001. (C) qPCR of classic white and brown adipocyte genes after 14 days in adipogenicmedium following 0, 3, or 14 days of ROS treatment. Genes were normalized
to TBP. Data are expressed asmeans± SEM (n=4;N=3). *P b 0.015; **P b 0.004; ***P b 0.006; ****P b 0.0001. (D) Representative UCP1 immunoﬂuorescent staining of hmrMSCs (M68),
UCP1 (red) and nucleus (DAPI, blue) (scale bar, 250 μm). (E)Western blotting for UCP1 (30 μg protein/lane) in hmrMSCs differentiated for 14 days following 0, 3, or 14 days of ROS stim-
ulation in adipogenic medium. UCP1 protein expression was normalized to GAPDH. Data are expressed as means ± SEM (n= 3; N= 3). *P b 0.035. Each experiment was performed at
least three times with cells from three independent donors (M38, M58, M68).
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170 J. Downey et al. / Bone 71 (2015) 164–170such as HO. In addition, due to their easy accessibility and reproducibil-
ity across donors, CD90− hmrMSCs will be a valuable source of progen-
itor cells for further studies and future therapies.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bone.2014.10.020.
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